Envestnet Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $432M | Buy |
2,281,431
+10,458
| +0.5% | +$1.97M | 0.1% | 171 |
|
|
2026
Q1 | $447M | Buy |
2,270,973
+245,150
| +12% | +$47.3M | 0.12% | 147 |
|
|
2025
Q4 | $372M | Buy |
2,025,823
+102,489
| +5% | +$18M | 0.11% | 163 |
|
|
2025
Q3 | $295M | Buy |
1,923,334
+146,557
| +8% | +$22.2M | 0.08% | 221 |
|
|
2025
Q2 | $248M | Sell |
1,776,777
-94,756
| -5% | -$13.3M | 0.07% | 249 |
|
|
2025
Q1 | $275M | Buy |
1,871,533
+97,751
| +6% | +$14.1M | 0.09% | 214 |
|
|
2024
Q4 | $232M | Buy |
1,773,782
+14,885
| +0.8% | +$2.08M | 0.07% | 242 |
|
|
2024
Q3 | $274M | Buy |
1,758,897
+49,930
| +3% | +$8.06M | 0.09% | 207 |
|
|
2024
Q2 | $267M | Buy |
1,708,967
+244,322
| +17% | +$36.8M | 0.09% | 200 |
|
|
2024
Q1 | $198M | Buy |
1,464,645
+101,555
| +7% | +$13.4M | 0.07% | 261 |
|
|
2023
Q4 | $184M | Buy |
1,363,090
+66,485
| +5% | +$8.64M | 0.08% | 256 |
|
|
2023
Q3 | $176M | Buy |
1,296,605
+410,826
| +46% | +$56.1M | 0.08% | 244 |
|
|
2023
Q2 | $127M | Sell |
885,779
-1,900,704
| -68% | -$280M | 0.06% | 287 |
|
|
2023
Q1 | $120M | Buy |
2,786,483
+2,038,791
| +273% | +$274M | 0.06% | 285 |
|
|
2022
Q4 | $101M | Buy |
747,692
+9,497
| +1% | +$1.19M | 0.05% | 311 |
|
|
2022
Q3 | $81M | Buy |
738,195
+228,475
| +45% | +$29M | 0.05% | 328 |
|
|
2022
Q2 | $67.4M | Buy |
509,720
+34,629
| +7% | +$4.54M | 0.04% | 364 |
|
|
2022
Q1 | $63M | Buy |
475,091
+45,914
| +11% | +$5.51M | 0.03% | 413 |
|
|
2021
Q4 | $50M | Buy |
429,177
+54,053
| +14% | +$6.36M | 0.02% | 496 |
|
|
2021
Q3 | $45.1M | Buy |
375,124
+84,510
| +29% | +$9.84M | 0.02% | 488 |
|
|
2021
Q2 | $34.8M | Buy |
290,614
+48,253
| +20% | +$5.29M | 0.02% | 571 |
|
|
2021
Q1 | $24.1M | Buy |
242,361
+34,132
| +16% | +$3.43M | 0.02% | 652 |
|
|
2020
Q4 | $20.8M | Buy |
208,229
+18,010
| +9% | +$1.91M | 0.02% | 608 |
|
|
2020
Q3 | $20.8M | Sell |
190,219
-3,468
| -2% | -$386K | 0.02% | 542 |
|
|
2020
Q2 | $20.5M | Buy |
193,687
+1,195
| +0.6% | +$123K | 0.02% | 512 |
|
|
2020
Q1 | $17.2M | Sell |
192,492
-35,338
| -16% | -$3.33M | 0.02% | 505 |
|
|
2019
Q4 | $22.7M | Sell |
227,830
-686
| -0.3% | -$64.6K | 0.02% | 486 |
|
|
2019
Q3 | $20.4M | Buy |
228,516
+10,988
| +5% | +$953K | 0.02% | 488 |
|
|
2019
Q2 | $18M | Buy |
217,528
+17,182
| +9% | +$1.35M | 0.02% | 513 |
|
|
2019
Q1 | $16.2M | Sell |
200,346
-111,591
| -36% | -$8.8M | 0.02% | 514 |
|
|
2018
Q4 | $23.7M | Buy |
311,937
+302,325
| +3,145% | +$23.6M | 0.04% | 324 |
|
|
2018
Q3 | $761K | Sell |
9,612
-106,480
| -92% | -$8.05M | ﹤0.01% | 821 |
|
|
2018
Q2 | $8.15M | Sell |
116,092
-2,399
| -2% | -$173K | 0.02% | 370 |
|
|
2018
Q1 | $8.3M | Sell |
118,491
-204,662
| -63% | -$14.2M | 0.02% | 273 |
|
|
2017
Q4 | $22.4M | Sell |
323,153
-762
| -0.2% | -$51.4K | 0.05% | 213 |
|
|
2017
Q3 | $21.9M | Sell |
323,915
-4,255
| -1% | -$269K | 0.05% | 199 |
|
|
2017
Q2 | $22.4M | Buy |
328,170
+1,334
| +0.4% | +$87.1K | 0.06% | 185 |
|
|
2017
Q1 | $20.4M | Buy |
326,836
+55,179
| +20% | +$3.21M | 0.07% | 195 |
|
|
2016
Q4 | $14.8M | Sell |
271,657
-83,643
| -24% | -$4.75M | 0.05% | 253 |
|
|
2016
Q3 | $23.4M | Sell |
355,300
-179
| -0.1% | -$11.7K | 0.09% | 171 |
|
|
2016
Q2 | $21.5M | Buy |
355,479
+18,163
| +5% | +$1.05M | 0.09% | 201 |
|
|
2016
Q1 | $19M | Buy |
337,316
+12,553
| +4% | +$754K | 0.08% | 215 |
|
|
2015
Q4 | $22.1M | Buy |
324,763
+22,630
| +7% | +$1.48M | 0.1% | 183 |
|
|
2015
Q3 | $19.2M | Buy |
302,133
+4,091
| +1% | +$269K | 0.1% | 192 |
|
|
2015
Q2 | $19M | Buy |
298,042
+92,165
| +45% | +$6.31M | 0.09% | 218 |
|
|
2015
Q1 | $14.1M | Buy |
205,877
+203,411
| +8,249% | +$14.1M | 0.07% | 267 |
|
|
2014
Q4 | $174K | Buy |
2,466
+513
| +26% | +$36.7K | ﹤0.01% | 1037 |
|
|
2014
Q3 | $139K | Sell |
1,953
-223
| -10% | -$16.3K | ﹤0.01% | 1197 |
|
|
2014
Q2 | $162K | Sell |
2,176
-5,626
| -72% | -$407K | ﹤0.01% | 1062 |
|
|
2014
Q1 | $506K | Sell |
7,802
-63
| -0.8% | -$4.07K | 0.01% | 649 |
|
|
2013
Q4 | $467K | Sell |
7,865
-431
| -5% | -$23.4K | 0.01% | 637 |
|
|
2013
Q3 | $431K | Sell |
8,296
-501
| -6% | -$25.2K | 0.01% | 640 |
|
|
2013
Q2 | $416K | Buy |
+8,797
| New | +$448K | 0.01% | 627 |
|
Other funds holding AZN
EP
IA
Envestnet Asset Management's AZN Position: Q2 2026 in Review
Envestnet Asset Management increased its AstraZeneca (AZN) stake by 0.46% in Q2 2026, buying an estimated $1.97M and bringing the position to 2,281,431 shares worth $432M. The position accounts for 0.1% of the portfolio, ranked #171.
Envestnet Asset Management first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $447M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Envestnet Asset Management held 2,281,431 shares of AstraZeneca worth $432M as of Q2 2026.
- Envestnet Asset Management bought 10,458 AstraZeneca shares in Q2 2026, an estimated $1.97M.
- AstraZeneca made up 0.1% of Envestnet Asset Management's portfolio in Q2 2026, its #171 holding.
- Envestnet Asset Management first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- Envestnet Asset Management's AstraZeneca position peaked at $447M in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.